课题基金 / 基金详情

Unplanned Early Readmissions of Hospitalized Patients with Cirrhosis

Unplanned Early Readmissions of Hospitalized Patients with Cirrhosis
住院肝硬化患者的意外提前再入院
批准号:
10384144
负责人:
Eric Orman
金额:
$9.01万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-15 至 2022-02-28
关键词:
Active LearningAscitesAwardBehavioralBiometryCaregiver BurdenCaringCharacteristicsCirrhosisClinical ResearchClinical SciencesClinical TrialsCognitiveConsensusDataData AnalysesDevelopment PlansDiseaseEligibility DeterminationEnrollmentEnvironmentExtramural ActivitiesFosteringFundingFutureGastrointestinal HemorrhageGoalsGrowth and Development functionHealthHealth Care Quality IndicatorsHealth PrioritiesHealth Services ResearchHealthcare SystemsHepatic EncephalopathyHepatologyHospice CareHospitalizationHospitalsIncidenceIndianaInfectionInformation NetworksInstitutesInterventionIntervention StudiesLeadLiver CirrhosisLiver diseasesMentorsMentorshipMethodologyMethodsModelingOutcomePalliative CarePatientsPhysiciansPopulationPositioning AttributeProcessProspective cohortProspective cohort studyPsychologyPublic HealthQualitative ResearchResearchResearch PersonnelResourcesRisk FactorsScientistSenior ScientistSeverity of illnessSocial WorkSpecialistStructureTranslational ResearchTransplantationTransplantation SurgeryUniversitiesValidationcare outcomescareercareer developmentcostcost estimatedesigneffective interventionend stage diseasefollow-uphigh riskhigh risk populationhospice environmenthospital readmissionimplementation scienceimprovedinnovationliver transplantationmodifiable riskmortalitymulti-component interventionmultidisciplinarypatient orientedpatient oriented researchpatient stratificationpredictive modelingprogramsprospectiveresearch and developmentrisk stratificationskillssocial factorstime use

项目摘要

项目成果

Eric Orman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Patients with liver cirrhosis who are discharged from the hospital have high rates of early hospital readmission, and these readmissions are a significant burden to the health care system. Reducing readmissions is a priority for the health care system, but requires a thorough understanding of modifiable risk factors leading to readmission. In addition, many patients who are readmitted to the hospital may benefit from hospice referral, which is underutilized in patients with cirrhosis, and which may also reduce readmissions. This proposal describes a career development plan that will enable the candidate to develop expertise in patient-oriented clinical research by acquiring the necessary skills in health services research, implementation science, palliative care, and biostatistics. The specific aims are to (1) determine the incidence and predictors of unplanned 30 day readmissions in patients with cirrhosis; (2) identify factors associated with preventable unplanned 30 day readmissions; and (3) develop criteria that identify hospitalized patients with cirrhosis who are suitable for hospice care. To achieve these aims, the candidate will (1) study detailed multidimensional characteristics of a large prospective cohort of hospitalized patients with cirrhosis; (2) systematically assess readmission preventability; and (3) convene an expert panel using the modified Delphi consensus process to identify criteria for hospice eligibility. The proposed career development plan integrates: close mentoring from a multidisciplinary team of senior scientists; advanced coursework in health services research, biostatistics, implementation science, and qualitative research; experiential learning through the conduct of the proposed research plan; and a highly supportive research environment. The mentorship team, which includes independent investigators with expertise in clinical and translational research in hepatology (Chalasani), health services research and implementation science (Boustani), palliative care and consensus methodology (Sachs), and observational and longitudinal data analysis and biostatistics (Gao), will guide the candidate's research and career development. The research environment at Indiana University includes multidisciplinary collaborative organizations such as the Indiana Clinical and Translational Sciences Institute and the Center for Health Innovation and Implementation Science, which will help foster the candidate's professional growth and career development. At the conclusion of this program, the candidate will be well positioned to become an independent physician- scientist conducting high quality health services research in cirrhosis.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.amjmed.2020.04.029
发表时间: 2020-12
期刊: The American journal of medicine
影响因子: --
作者: [Shamseddeen H, Patidar KR, Ghabril M, Desai AP, Nephew L, Kuehl S, Chalasani N, Orman ES]
通讯作者: Orman ES
Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring.
代偿性 NASH 肝硬化患者肝脏生化的自发波动:对药物肝毒性监测的影响。
DOI: 10.1007/s40264-019-00896-1
发表时间: 2020
期刊: Drug safety
影响因子: 4.2
作者: [Shamseddeen,Hani, Vilar-Gomez,Eduardo, Chalasani,Naga, Myers,RobertP, Subramanian,GMani, Shlevin,HaroldH, Allgood,AdamE, Orman,EricS]
通讯作者: Orman,EricS
Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis.
肝硬化患者复发艰难梭菌感染的发病率和危险因素。
DOI: 10.14309/ctg.0000000000000189
发表时间: 2020
期刊: Clinical and translational gastroenterology
影响因子: 3.6
作者: [Phatharacharukul,Parkpoom, Purpura,RussellD, Gandhi,Devika, Xu,Huiping, Bickett-Burkhart,Katie, Chalasani,Naga, Fischer,Monika, Orman,EricS]
通讯作者: Orman,EricS
DOI: 10.14309/ajg.0000000000000911
发表时间: 2020-11
期刊: The American journal of gastroenterology
影响因子: --
作者: [Are VS, Knapp SM, Banerjee A, Shamseddeen H, Ghabril M, Orman E, Patidar KR, Chalasani N, Desai AP]
通讯作者: Desai AP
12
    The Transitional Liver Clinic (TLC): Reducing Liver Disease Readmission
    The Cirrhosis Medical Home: A Feasibility Study
    The Cirrhosis Medical Home: A Feasibility Study
    Unplanned Early Readmissions of Hospitalized Patients with Cirrhosis
    海外基金